Endometrial Cancer Trial, Recruiting NCT06666192 Sponsor: Ohio State University Comprehensive Cancer Center Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT06666192
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your local health clinic is part of this study if it provides preventive health care to residents in specific targeted neighborhoods
  • Healthcare workers (such as doctors, nurses, nurse practitioners, or physician assistants) and office staff who work at a participating clinic, are involved in the patient screening process, and can speak, read, and write English
  • Patients who receive health care and screening services at the participating clinics
  • Community members who live in the specific neighborhoods surrounding the participating clinics

Who may not be able to join:

  • Healthcare workers or staff who cannot speak, read, and write English
  • Clinics that do not provide preventive health care to residents in the targeted neighborhoods
  • Community members or patients who do not live or receive care within the specific targeted neighborhoods (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Electra D Paskett, PhD, Ohio State University Comprehensive Cancer Center

Phone: 800-293-5066

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ohio State University Comprehensive Cancer Center
Registry
ClinicalTrials.gov
Start date
12 March 2024
Est. completion
31 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Up to date (UTD) status for all three screenings (Early Intervention Wave); Status of follow-up for abnormal tests (Early Intervention Wave)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov